ANXA2 and cancer: Cytoskeletal-associated proteins play an active role in coordinating the adhesion and migration machinery in cancer progression, and targeting annexin A2 could effectively inhibit tumor cell adhesion, migration and in vivo grafting (Staquicini et al., 2017).